TABLE 1.
GA17PH |
PGPH |
crAssPH |
HAdV |
NoV |
||||||
sp | se | sp | se | sp | se | sp | se | sp | se | |
Austria | 1.00 | 0.88 | 0.79 | 0.00 | 1.00 | 1.00 | 1.00 | 0.88 | 1.00 | 1.00 |
Germany | 0.93 | 1.00 | 0.93 | 0.00 | 1.00 | 1.00 | 0.93 | 0.60 | 0.71 | 0.80 |
Finland | 1.00 | 0.86 | 0.94 | 1.00 | 1.00 | 1.00 | 1.00 | 0.71 | 0.82 | 1.00 |
Portugal | 0.88 | 1.00 | 0.94 | 1.00 | 0.38 | 1.00 | 1.00 | 0.14 | 0.63 | 0.57 |
Spain | 0.95 | 0.83 | 0.65 | 1.00 | 0.10 | 1.00 | 1.00 | 0.67 | 0.55 | 1.00 |
GA17PH, phages infecting human-associated Bacteroides thetaiotaomicron strain GA17; PGPH, phages infecting porcine-associated B. fragilis strain PG76; BACPH, sum of GA17PH and PGPH; crAssPH, crAssphage; HAdV, human Adenoviruses; and NoV, GI + GII Noroviruses.